229 related articles for article (PubMed ID: 31062662)
21. Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical
Kahaly GJ; Steiner L; van der Lee MMC; van Achterberg TAE; Arends RJ; Karstens WFJ; Weirauch T; Henseling J; Frommer L; Wolf J; George A
Thyroid; 2023 Jun; 33(6):732-742. PubMed ID: 37016815
[No Abstract] [Full Text] [Related]
22. Stimulatory TSH-Receptor Antibodies and Oxidative Stress in Graves Disease.
Diana T; Daiber A; Oelze M; Neumann S; Olivo PD; Kanitz M; Stamm P; Kahaly GJ
J Clin Endocrinol Metab; 2018 Oct; 103(10):3668-3677. PubMed ID: 30099546
[TBL] [Abstract][Full Text] [Related]
23. TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes
Boutin A; Krieger CC; Marcus-Samuels B; Klubo-Gwiezdzinska J; Neumann S; Gershengorn MC
Front Endocrinol (Lausanne); 2020; 11():276. PubMed ID: 32425890
[TBL] [Abstract][Full Text] [Related]
24. A rapid homogenous bioassay for detection of thyroid-stimulating antibodies based on a luminescent cyclic AMP biosensor.
Miao LY; Kim HJ; Whitlatch K; Jaiswal D; Navarro A; Egan R; Olivo PD
J Immunol Methods; 2022 Feb; 501():113199. PubMed ID: 34871593
[TBL] [Abstract][Full Text] [Related]
25. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
Hidaka A; Okajima F; Ban T; Kosugi S; Kondo Y; Kohn LD
J Clin Endocrinol Metab; 1993 Nov; 77(5):1164-9. PubMed ID: 8077307
[TBL] [Abstract][Full Text] [Related]
26. PDGF enhances orbital fibroblast responses to TSHR stimulating autoantibodies in Graves' ophthalmopathy patients.
van Steensel L; Hooijkaas H; Paridaens D; van den Bosch WA; Kuijpers RW; Drexhage HA; van Hagen PM; Dik WA
J Clin Endocrinol Metab; 2012 Jun; 97(6):E944-53. PubMed ID: 22438231
[TBL] [Abstract][Full Text] [Related]
27. Thyrotropin Causes Dose-dependent Biphasic Regulation of cAMP Production Mediated by G
Neumann S; Malik SS; Marcus-Samuels B; Eliseeva E; Jang D; Klubo-Gwiezdzinska J; Krieger CC; Gershengorn MC
Mol Pharmacol; 2020 Jan; 97(1):2-8. PubMed ID: 31704717
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
29. Complete inhibition of rhTSH-, Graves' disease IgG-, and M22-induced cAMP production in differentiated orbital fibroblasts by a low-molecular-weight TSHR antagonist.
van Zeijl CJ; van Koppen CJ; Surovtseva OV; de Gooyer ME; Plate R; Conti P; Karstens WJ; Timmers M; Saeed P; Wiersinga WM; Miltenburg AM; Fliers E; Boelen A
J Clin Endocrinol Metab; 2012 May; 97(5):E781-5. PubMed ID: 22419705
[TBL] [Abstract][Full Text] [Related]
30. Molecular interactions between the TSH receptor and a Thyroid-stimulating monoclonal autoantibody.
Sanders J; Miguel RN; Bolton J; Bhardwaja A; Sanders P; Nakatake N; Evans M; Furmaniak J; Smith BR
Thyroid; 2007 Aug; 17(8):699-706. PubMed ID: 17725428
[TBL] [Abstract][Full Text] [Related]
31. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding.
Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS
Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759
[TBL] [Abstract][Full Text] [Related]
32. Thyroid-stimulating hormone receptor (TSHR) fusion proteins in Graves' disease.
Holthoff HP; Uhland K; Kovacs GL; Reimann A; Adler K; Wenhart C; Ungerer M
J Endocrinol; 2020 Aug; 246(2):135-147. PubMed ID: 32573180
[TBL] [Abstract][Full Text] [Related]
33. Persistent cAMP signaling by TSH receptors revealed by phosphodiesterase inhibition.
Geras-Raaka E; Neumann S; Gershengorn MC
Thyroid; 2013 Nov; 23(11):1484-9. PubMed ID: 23713896
[TBL] [Abstract][Full Text] [Related]
34. Measurement of thyroid stimulating immunoglobulins using a novel thyroid stimulating hormone receptor-guanine nucleotide-binding protein, (GNAS) fusion bioassay.
Pierce M; Sandrock R; Gillespie G; Meikle AW
Clin Exp Immunol; 2012 Nov; 170(2):115-21. PubMed ID: 23039881
[TBL] [Abstract][Full Text] [Related]
35. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
[TBL] [Abstract][Full Text] [Related]
36. Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease.
Mizutori Y; Chen CR; Latrofa F; McLachlan SM; Rapoport B
J Clin Endocrinol Metab; 2009 Mar; 94(3):927-35. PubMed ID: 19066298
[TBL] [Abstract][Full Text] [Related]
37. The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.
Lenzner C; Morgenthaler NG
Thyroid; 2003 Dec; 13(12):1153-61. PubMed ID: 14751037
[TBL] [Abstract][Full Text] [Related]
38. Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor.
Hoshina M; Ojima S; Kawasaki A; Doi K; Ohta S; Inoue A; Murayama H
J Immunol Methods; 2024 May; 528():113655. PubMed ID: 38447802
[TBL] [Abstract][Full Text] [Related]
39. Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients.
van Zeijl CJ; Fliers E; van Koppen CJ; Surovtseva OV; de Gooyer ME; Mourits MP; Wiersinga WM; Miltenburg AM; Boelen A
Thyroid; 2010 May; 20(5):535-44. PubMed ID: 20384487
[TBL] [Abstract][Full Text] [Related]
40. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
